<DOC>
	<DOCNO>NCT00848068</DOCNO>
	<brief_summary>To evaluate effect FID 114657 tear film lipid layer thickness patient dry eye .</brief_summary>
	<brief_title>Evaluation FID 114657 Tear Film Lipid Layer Thickness</brief_title>
	<detailed_description />
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<criteria>Informed consent document HIPAA privacy document must read , sign dated patient legally authorize representative conducting procedure . Patients ( minimum age 18 ) dry eye . Criteria diagnosis must include follow characteristic : Positive response question , `` Do ever feel eye ? `` ; Baseline LLT value ≤75nm ( OU ) , vary ±15 nm course 10minute observation period , difference LLT two eye must ≤15nm , increase LLT three forceful blink must ≤15nm . Patients must bestcorrected Snellen visual acuity 20/70 good eye . Able willing follow study instruction . Use topical ocular drop within 12 hour study visit ; use topical ocular ointment within 36 hour study visit . In addition , use concomitant topical ocular drug study period . History evidence ocular intraocular surgery either eye within past six month . History evidence serious ocular trauma either eye within past six month . History intolerance hypersensitivity component study medication . History and/or current evidence glaucoma ocular hypertension either eye . History and/or current evidence active intraocular inflammation either eye ( i.e. , retina/macula/choroid ) . History evidence epithelial herpes simplex keratitis ( dendritic keratitis ) ; vaccinia ; active recent varicella viral disease cornea and/or conjunctiva ; ocular rosacea ; chronic bacterial disease cornea and/or conjunctiva and/or eyelid ; mycobacterial infection eye ; and/or fungal disease eye . Ocular condition active acute blepharitis , conjunctival infection , iritis , conjunctival abnormality ( include pinguecula great 1mm diameter , locate closer 2mm limbus elevate 0.2mm ) , eyelid abnormality ( include entropion ectropion ) ocular condition may , opinion investigator , preclude safe administration test article . Patients use systemic medication may contribute dry eye ( e.g . cold allergy medication , tricyclic antidepressant , hormone replacement therapy ) may enrol study unless stable dose regimen minimum 30 day prior study visit . Any ocular systemic medical condition might influence tear film ( dry eye ) . Individuals unwilling discontinue contact lens wear study period . Contact lens wear must discontinue minimum 12 hour prior study visit . Individuals unwilling discontinue use cosmetic ( eyeliner , mascara eye shadow ) facial cream around eyelid day study . Participation investigational drug device study within 30 day enter study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>lipid layer thickness</keyword>
</DOC>